Dr. Agarwal's Eye Hospital Limited (BOM: 526783)

Market Cap	19.19B
Revenue (ttm)	3.41B
Net Income (ttm)	489.30M
Shares Out	4.70M
EPS (ttm)	104.11
PE Ratio	39.22
Forward PE	n/a
Dividend	5.00 (0.12%)
Ex-Dividend Date	Aug 19, 2024

Volume	349
Open	4,100.00
Previous Close	4,078.45
Day's Range	4,013.00 - 4,141.00
52-Week Range	2,199.00 - 4,198.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 18, 2024

About Dr. Agarwal's Eye Hospital

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retino...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1957
• Employees: 1,113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526783

Financial Performance

In 2023, Dr. Agarwal's Eye Hospital's revenue was 3.19 billion, an increase of 19.10% compared to the previous year's 2.68 billion. Earnings were 463.60 million, an increase of 25.57%.